회사의 펀더멘털은 비교적 아주 건전한한 편입니다. 회사의 밸류에이션은 과소 평가된으로 간주됩니다. 기관의 인지도는 매우 높은입니다. 지난 30일 동안 여러 애널리스트들이 이 회사를 매수로 평가했습니다. 회사는 주식시장에서 양호한 성과를 보이고 있으며, 견조한 펀더멘털과 기술적 지표가 현재의 추세를 뒷받침하고 있습니다. 주가는 지지선과 저항선 사이에서 횡보하고 있으며, 범위 매매 기반의 스윙 트레이딩에 적합한 상황입니다.
주식 점수
관련 정보
산업 순위
98 / 470
전체 순위
162 / 4721
산업
소프트웨어 및 IT 서비스
저항선 & 지지선
데이터 없음
레이더 차트
현재 가격
과거
분석가 목표가
18
명의 분석가를 기준으로
매수
현재 등급
212.837
목표 가격
+38.69%
상승 여력
면책 조항: 애널리스트 평가 및 목표 주가는 정보 제공을 위한 목적으로 LSEG에서 제공되며, 투자 조언으로 간주되지 않습니다.
기업 하이라이트
강점위험 요소
EPAM Systems, Inc. provides digital engineering, cloud, and artificial intelligence-enabled transformation services. The Company's software product and platform development services, including product research, customer experience design and prototyping, program management, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, managed services, as well as cross-platform migration and modernizing legacy platforms. Its segments include North America and Europe. It offers complex software product development services. It partners with global pharmaceutical, medical and scientific technology, biotechnology companies and retail pharmacies to deliver scientific informatics and enterprise technology solutions. It offers health data analytics. It also offers a set of AI-enabled capabilities to clients in banking, capital markets and other financially regulated businesses.
EPAM Systems, Inc. provides digital engineering, cloud, and artificial intelligence-enabled transformation services. The Company's software product and platform development services, including product research, customer experience design and prototyping, program management, component design and integration, full lifecycle software testing, product deployment and end-user customization, performance tuning, product support and maintenance, managed services, as well as cross-platform migration and modernizing legacy platforms. Its segments include North America and Europe. It offers complex software product development services. It partners with global pharmaceutical, medical and scientific technology, biotechnology companies and retail pharmacies to deliver scientific informatics and enterprise technology solutions. It offers health data analytics. It also offers a set of AI-enabled capabilities to clients in banking, capital markets and other financially regulated businesses.